Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis picks up its development option in $700M rare-disease pact
Novartis picks up its development option in $700M rare-disease pact
Novartis picks up its development option in $700M rare-disease pact
Submitted by
admin
on September 10, 2013 - 11:25am
Source:
Fierce Biotech
News Tags:
Novartis
Camarus
CAM2029
acromegaly
Headline:
Novartis picks up its development option in $700M rare-disease pact
Do Not Allow Advertisers to Use My Personal information
